How can life science technology providers support the pharma industry in the transition toward more digitally connected operations? Katrina Rice weighed in with Pharma's Almanac. Read her full answer here: https://lnkd.in/gxZTgyu5 #lifesciences #pharma #biometricsservices #clinicaltrials
eClinical Solutions’ Post
More Relevant Posts
-
Achieve commercial success with the real-time tracking of market events for pharma and biotech, clinical and regulatory analysis, and a drug’s likelihood of approval in Citeline Commercial's Biomedtracker. View the Biomedtracker video to find out why our analyst Zhyar considers Ask the Analyst to be an important benefit of Citeline to drive your commercial strategy forward. Learn more: https://ow.ly/rTTR50Qq5j6 #Biomedtracker #Pharma #Biotech
To view or add a comment, sign in
-
Achieve commercial success with the real-time tracking of market events for pharma and biotech, clinical and regulatory analysis, and a drug’s likelihood of approval in Citeline Commercial's Biomedtracker. View the Biomedtracker video to find out why our analyst Zhyar considers Ask the Analyst to be an important benefit of Citeline to drive your commercial strategy forward. Learn more: https://ow.ly/X0ux50Qcuzl #Biomedtracker #Pharma #Biotech
To view or add a comment, sign in
-
Achieve commercial success with the real-time tracking of market events for pharma and biotech, clinical and regulatory analysis, and a drug’s likelihood of approval in Citeline Commercial's Biomedtracker. View the Biomedtracker video to find out why our analyst Zhyar considers Ask the Analyst to be an important benefit of Citeline to drive your commercial strategy forward. Learn more: https://ow.ly/W4jX50QkbLv #Biomedtracker #Pharma #Biotech
To view or add a comment, sign in
-
Achieve commercial success with the real-time tracking of market events for pharma and biotech, clinical and regulatory analysis, and a drug’s likelihood of approval in Citeline Commercial's Biomedtracker. View the Biomedtracker video to find out why our analyst Zhyar considers Ask the Analyst to be an important benefit of Citeline to drive your commercial strategy forward. Learn more: https://ow.ly/nwOU50QsGU2 #Biomedtracker #Pharma #Biotech
To view or add a comment, sign in
-
Facilitating Partnerships within Biopharma | Crafting CGT and Biologics Manufacturing Conferences Across Europe
𝗡𝗮𝘃𝗶𝗴𝗮𝘁𝗶𝗻𝗴 𝘁𝗵𝗲 𝗣𝗮𝘁𝗲𝗻𝘁 𝗘𝘅𝗽𝗶𝗿𝘆 𝗪𝗮𝘃𝗲: 𝗔 𝗦𝘁𝗿𝗮𝘁𝗲𝗴𝗶𝗰 𝗢𝘂𝘁𝗹𝗼𝗼𝗸 𝗳𝗼𝗿 𝗣𝗵𝗮𝗿𝗺𝗮 The next five years are pivotal for pharma, with a multitude of patents set to expire. Andrew Pannu's analysis brings this into focus, charting a course from AbbVie's Humira to Merck Group's Keytruda, and more, facing the generic tide. As the 'at-risk' revenue potentially swells from $𝟰𝟭𝗕 𝘁𝗼 $𝟲𝟳𝗕, industry leaders are on the cusp of reinvention. This infographic is a clarion call to bolster R&D and innovate, ensuring the vitality of the biopharma sector. #PharmaPatents #BiopharmaStrategy
To view or add a comment, sign in
-
-
Achieve commercial success with the real-time tracking of market events for pharma and biotech, clinical and regulatory analysis, and a drug’s likelihood of approval in Citeline Commercial's Biomedtracker. View the Biomedtracker video to find out why our analyst Zhyar considers Ask the Analyst to be an important benefit of Citeline to drive your commercial strategy forward. Learn more: https://ow.ly/wmux50QnXGS #Biomedtracker #Pharma #Biotech
To view or add a comment, sign in
-
As we dive deeper into the challenges and opportunities facing drug manufacturers, our latest blog covers the top 10 patent expiries that will impact some of the biggest players in the field over the next five years. With over $200,000 billion worth of revenue at risk, the pressure is on for these companies to find new avenues for growth and innovation. Learn more about the challenges and opportunities that lie ahead for pharma giants as they navigate through this period of change and innovation: https://lnkd.in/eBaqAhWG #GlobalGrowthPartners #Pharma #Top10 #DrugPatent #LifeSciences
To view or add a comment, sign in
-
Achieve commercial success with the real-time tracking of market events for pharma and biotech, clinical and regulatory analysis, and a drug’s likelihood of approval in Citeline Commercial's Biomedtracker. View the Biomedtracker video to find out why our analyst Zhyar considers Ask the Analyst to be an important benefit of Citeline to drive your commercial strategy forward. Learn more: https://ow.ly/fFAE50QcuHS #Biomedtracker #Pharma #Biotech
To view or add a comment, sign in
-
Do you really think about your electricity when you flip the light switch? Likewise, we don’t believe you should think about your data … you’ve got patients to get your therapy to and investors to convince to remain patient (pun intended). Axtria DataMAx Emerging Pharma can easily be deployed within six weeks to establish an end-to-end data management system Ttrusted by many of the top 20 global pharmaceutical companies for really big stuff Ready to scale with you from a handful of MSLs, market prep, launch prep, launch, rapid post-launch adjustments, Board-worthy insights, and omnichannel ‘surround sound’. See it to believe it. It’s ADEPt. Give us a call. Work with entrepreneurs who empathize and thrill in your journey.
Are you an emerging pharma company with growth on your mind? Look no further. Learn more: https://lnkd.in/d7pdAUAi #emergingpharma #healthtech #pharma #lifesciences
To view or add a comment, sign in
-
Dive into the fundamentals of #freezedrying with Steven L. Nail, scientific advisory board member at LyoHUB! Gain invaluable insights into essential processes for the #pharmaceutical and #biotech industries by watching the recorded presentation on our website. Click the link to access the video now! https://lnkd.in/gzH4uWdS
To view or add a comment, sign in
-